Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Stimcell Energetics Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Stimcell Energetics Inc (CMXC) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2026

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/CMXC/competitors                    

                        https://api.csimarket.com/api/v1/companies/CMXC/relationships                    

                        https://api.csimarket.com/api/v1/companies/CMXC/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

CMXC Stock Performance relative to its Competitors

CMXC Competitors (weighted) Percent change over the selected range

Stimcell Energetics Inc's Comment on Competition and Industry Peers

The company operates in the competitive markets of diabetes management and pain management treatments. Its eBalance® Pro and eBalance® Home Systems utilize microcurrent therapy, a method not yet widely accepted in traditional medicine, resulting in no clearly defined direct competitors. Indirect competition includes pharmaceutical companies producing drugs for diabetes complications, manufacturers of glucose monitoring devices, and producers of pharmaceuticals for various diseases and symptoms. The company also faces competition from firms developing and commercializing electrical and microcurrent therapy technologies for acute, chronic, and postoperative pain treatment. The company's eBalance® Technology is not patented. Named competitors include BodiHealth Systems and Electromedical Products International, Inc.

Competitor data is not yet available for Stimcell Energetics Inc.

Stimcell Energetics Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.

Competitor	Basis	Confidence	Active	Sources
Electromedical Products International, Inc.	Filings	85%	2022 to 2026	3
BodiHealth Systems	Filings	85%	2022 to 2026	3

Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Stimcell Energetics Inc's named competitors require a Commercial License.

Unlock Commercial Access

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Confidence reflects evidence strength.